16 April 2018

Redefining Success In IVF: Synchrony Brings In A New Era, A New Hope For Infertile Couples

  Everything needs a new perspective. Things which have been created needs a newer innovations, imagination and thanks to science as we are advancing ...

RECENT ARTICLES

 

Everything needs a new perspective. Things which have been created needs a newer innovations, imagination and thanks to science as we are advancing well! Today, we are witnessing noteworthy progress in our understanding of reproductive medicine, embryonic development, and the IVF process, along with the improvement of powerful and validated new genomics related tools that are bringing in an era in which clinical results can improve drastically,redefining what success means.

 

A successful IVF requires that both the embryo and the endometrium are synchronized, so that IVF specialists can transfer the right embryo at the right time. “The success of IVF depends on a lot of factors such as the age of the woman, the quality of the embryo, status of the uterus etc. But the two major factors to consider for enhancing the chances of a successful pregnancy during an IVF treatment are a chromosomally normal embryo and a receptive endometrium. If both the embryo and the endometrium are coordinated, the IVF clinician can transfer the right embryo at the right time. Recently launched SYNCHRONY by Igenomix combines ERA and PGS. It covers the two critical factors to achieve your goal, a healthy baby at home.” Says Dr. Rajni Khajuria, Lab Director, Igenomix India.

IVF treatments continue to evolve. The new product “Synchrony” by Igenomix can provide higher delivery rates with fewer treatment cycles. This path breaking new product brings the advantage of Endometrial Receptivity Analysis (ERA) and Preimplantation Genetic Screening (PGS) together to help IVF specialists achieve a successful pregnancy for their patients.

Analyzing and detecting the window of implantation (WOI) is really important so as to prevent implantation failures. Since long, endometrial tissue was checked only through ultrasound.

ERA is a state-of-the-art diagnostic method, developed and patented by Igenomix in 2009. The development of this diagnostic technique is based over the 10-year of research. ERA determines whether the woman is receptive on the day, when the biopsy is performed. If the result is positive then that is the WOI for that particular patient.

Even after a successful implantation there are many cases where the pregnancy ends up in a miscarriage in the first trimester. This mostly occurs due to chromosomal abnormalities in the embryo. Over 50% of spontaneous miscarriages are caused by chromosomal abnormalities. IGENOMIX’s PGS with the added advantage of MitoScore improves the pregnancy rate by 70-80% by a single embryo transfer. PGS uses the latest next generation sequencing (NGS) technology to screen the embryos for chromosomal abnormalities of all 24 chromosomes, hence increasing the chances of conception by 60% through IVF.

So enhanced delivery rates in fewer treatment cycles with SYNCHRONY is now a reality.

Topics: top-news

Do you want to start using our Genetic Services?

For further assistance please contact our customer support team by phone or e-mail

Contact us

Igenomix is in the media

Igenomix is not affiliated with any news outlet or publication identified above. News coverage does not constitute an endorsement of Igenomix or its products.

Newsletter subscription